2492
華新科
+7.50 (+2.50%)307.5014,846成交張數33.71本益比2.19股價淨值比0.83%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入
營業收入202536,463年增 +4.9%
毛利率202517.3%最新一期
營業利益率20255.8%最新一期
每股盈餘20254.74年增 -22.9%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 營業成本合計 | 76.4% | 74.0% | 39.6% | 65.6% | 68.4% | 70.3% | 82.2% | 82.2% | 81.4% | 82.7% | |
| 營業毛利（毛損） | 23.6% | 26.0% | 60.4% | 34.4% | 31.6% | 29.7% | 17.8% | 17.8% | 18.6% | 17.3% | |
| 營業毛利（毛損）淨額 | 23.6% | 26.0% | 60.4% | 34.4% | 31.6% | 29.7% | 17.8% | 17.8% | 18.6% | 17.3% | |
| 推銷費用 | 5.5% | 5.2% | 3.6% | 3.7% | 3.8% | 4.2% | 5.0% | 5.0% | 4.9% | 4.8% | |
| 管理費用 | 2.8% | 2.6% | 2.0% | 2.8% | 3.1% | 3.1% | 3.8% | 4.1% | 4.5% | 4.0% | |
| 研究發展費用 | 2.9% | 2.9% | 2.0% | 2.3% | 2.4% | 2.5% | 3.2% | 3.2% | 3.0% | 2.7% | |
| 營業費用合計 | 11.2% | 10.8% | 7.6% | 8.8% | 9.4% | 9.8% | 12.0% | 12.3% | 12.4% | 11.5% | |
| 營業利益（損失） | 12.4% | 15.2% | 52.8% | 25.5% | 22.2% | 19.9% | 5.8% | 5.5% | 6.3% | 5.8% | |
| 利息收入 | – | – | – | – | 1.0% | 1.1% | 1.5% | 3.3% | 3.9% | 4.2% | |
| 其他收入 | 0.9% | 1.0% | 0.8% | 1.7% | 1.0% | 1.1% | 1.1% | 1.0% | 0.9% | 1.6% | |
| 其他利益及損失淨額 | 0.5% | 0.0% | -0.4% | 0.8% | -0.2% | 0.5% | 0.7% | 0.5% | 3.2% | -1.5% | |
| 財務成本淨額 | 0.5% | 0.4% | 0.2% | 0.3% | 0.5% | 0.5% | 0.7% | 1.2% | 1.3% | 1.5% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | 0.9% | 0.8% | 0.7% | 2.1% | 1.9% | 3.1% | 1.8% | 1.6% | 1.4% | 1.6% | |
| 營業外收入及支出合計 | 1.8% | 1.3% | 0.9% | 4.2% | 3.1% | 5.3% | 4.2% | 5.2% | 8.0% | 4.4% | |
| 稅前淨利（淨損） | 14.3% | 16.6% | 53.6% | 29.8% | 25.4% | 25.3% | 10.0% | 10.6% | 14.3% | 10.2% | |
| 所得稅費用（利益）合計 | 1.9% | 3.6% | 10.6% | 6.3% | 5.1% | 4.0% | 3.5% | 2.5% | 3.3% | 2.0% | |
| 繼續營業單位本期淨利（淨損） | 12.4% | 13.0% | 43.0% | 23.5% | 20.3% | 21.3% | 6.5% | 8.1% | 11.0% | 8.2% | |
| 本期淨利（淨損） | 12.4% | 13.0% | 43.0% | 23.5% | 20.3% | 21.3% | 6.5% | 8.1% | 11.0% | 8.2% | |
| 確定福利計畫之再衡量數 | -0.3% | -0.2% | -0.1% | 0.0% | -0.1% | 0.0% | 0.0% | -0.1% | 0.1% | -0.1% | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | -1.2% | 0.8% | 2.6% | 4.1% | -0.1% | 4.7% | -4.7% | 9.1% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目 | – | – | 1.0% | 3.1% | 0.0% | -1.4% | -3.0% | 2.0% | -1.3% | 1.8% | |
| 與不重分類之項目相關之所得稅 | – | – | – | – | – | – | -0.1% | 0.0% | 0.0% | -0.0% | |
| 不重分類至損益之項目： | – | – | – | 4.0% | 2.5% | 2.7% | -3.0% | 6.5% | -5.9% | 10.8% | |
| 國外營運機構財務報表換算之兌換差額 | -5.1% | -1.3% | -0.5% | -3.1% | -0.8% | 0.1% | 3.2% | -1.5% | 4.9% | -1.7% | |
| 透過其他綜合損益按公允價值衡量之債務工具投資未實現評價損益 | – | – | – | – | – | – | -0.2% | 0.0% | -0.1% | 0.1% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | – | – | -0.7% | 0.0% | -0.1% | 0.6% | -0.4% | 1.1% | -0.3% | |
| 後續可能重分類至損益之項目： | – | – | – | -3.8% | -0.7% | 0.0% | 3.6% | -1.8% | 5.8% | -2.0% | |
| 其他綜合損益（淨額） | -3.8% | 4.8% | -0.9% | 0.2% | 1.8% | 2.7% | 0.6% | 4.7% | -0.1% | 8.9% | |
| 本期綜合損益總額 | 8.6% | 17.8% | 42.0% | 23.7% | 22.0% | 24.0% | 7.1% | 12.8% | 11.0% | 17.1% | |
| 母公司業主（淨利∕損） | 11.6% | 12.1% | 41.3% | 22.1% | 18.6% | 18.8% | 4.7% | 6.1% | 8.6% | 6.3% | |
| 非控制權益（淨利∕損） | 0.8% | 0.9% | 1.7% | 1.4% | 1.6% | 2.4% | 1.8% | 2.1% | 2.4% | 1.9% | |
| 母公司業主（綜合損益） | 7.8% | 16.5% | 40.6% | 22.2% | 19.6% | 21.2% | 5.9% | 10.6% | 8.8% | 12.6% | |
| 非控制權益（綜合損益） | 0.8% | 1.3% | 1.5% | 1.6% | 2.4% | 2.9% | 1.2% | 2.3% | 2.1% | 4.5% | |
| 基本每股盈餘 | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 繼續營業單位淨利（淨損） | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 稀釋每股盈餘 | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 備供出售金融資產未實現評價損益 | 2.3% | 3.1% | 0.0% | – | – | – | – | – | – | – | |
| 採用權益法認列關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | -0.7% | 3.2% | -0.2% | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。